Home HomeSwedenLivingWorld world_2_fill WorldBusiness BusinessSports sports-soccer SportsEntertainmentEntertain

The UK Approves Alzheimer's Medication

Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom.

» Updated: 07 September 2024, 08:43

» Published: 24 August 2024

The UK Approves Alzheimer's Medication
Photo: Martina Holmberg/TT

Alzheimer's patients and their relatives had high hopes that the braking medicine Leqembi would be approved in the EU for the treatment of early Alzheimer's disease. But as a cold shower in the middle of the summer, the EMA said no.

Now the medicine is getting permission in the UK, for certain patient groups, writes the company Bioarctic in a press release. For example, it will not apply to patients with a double set of the Alzheimer's risk gene ApoE4, which is about 10-15 percent of patients.

It also seems very unclear whether the medicine will be subsidized by the British healthcare system NHS.

According to the EMA's decision in July, Leqembi indeed affects the underlying causes of Alzheimer's, but the effect was small on patients' symptoms and disease progression. The health benefit is not sufficient in relation to potential drawbacks and side effects, such as swelling and risk of bleeding in the brain, according to the EMA.

With roughly the same reasoning, the British authority Nice assesses that the medicine will not be subsidized.

The medicine has previously been approved in, among other countries, the USA, Japan, and China. The Swedish company Bioarctic, which is behind the discovery that forms the basis for the medicine, has requested a review of the EMA's decision.

Tags
TTT
By TTThis article has been altered and translated by Sweden Herald

More news

New French obstacles for Airbnb
1 MIN READ

New French obstacles for Airbnb

The Government Seeks Support for Those Affected by Northvolt
1 MIN READ

The Government Seeks Support for Those Affected by Northvolt

The regional tax will be raised next year
1 MIN READ

The regional tax will be raised next year

Astra Zeneca's China Chief Arrested by Police
1 MIN READ

Astra Zeneca's China Chief Arrested by Police

More rate cuts - but risk of turmoil with Trump
2 MIN READ

More rate cuts - but risk of turmoil with Trump

Svantesson: Trump's policy may increase inflation
2 MIN READ

Svantesson: Trump's policy may increase inflation

Major Banks Lower Mortgage Rates
1 MIN READ

Major Banks Lower Mortgage Rates

Central Bank Economist: Central Bank Cuts Interest Rate Too Late
2 MIN READ

Central Bank Economist: Central Bank Cuts Interest Rate Too Late

How You Are Affected by Lowered Interest Rates
2 MIN READ

How You Are Affected by Lowered Interest Rates

Thedéen expects turmoil after Trump's victory
2 MIN READ

Thedéen expects turmoil after Trump's victory

Inflation upswing does not threaten interest rate cuts
3 MIN READ

Inflation upswing does not threaten interest rate cuts

The Stockholm Stock Exchange Continues Upwards
1 MIN READ

The Stockholm Stock Exchange Continues Upwards

Most up on Asian stock exchanges
1 MIN READ

Most up on Asian stock exchanges

This is how your wallet can be affected by Trump's victory
2 MIN READ

This is how your wallet can be affected by Trump's victory

Cheerful on Wall Street after Trump win
1 MIN READ

Cheerful on Wall Street after Trump win

Thousand-kronor notes to be picked up when the Central Bank increases the pace
3 MIN READ

Thousand-kronor notes to be picked up when the Central Bank increases the pace

Swish up and running again after disruption
1 MIN READ

Swish up and running again after disruption

Trump's company is soaring on the stock exchange
1 MIN READ

Trump's company is soaring on the stock exchange

Swedish Export Threatened by Trump Victory
2 MIN READ

Swedish Export Threatened by Trump Victory

Sameby's appeal against mining company rejected
1 MIN READ

Sameby's appeal against mining company rejected